nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—XDH—Procarbazine—hematologic cancer	0.173	0.223	CbGbCtD
Pyrazinamide—XDH—Daunorubicin—hematologic cancer	0.0927	0.12	CbGbCtD
Pyrazinamide—AOX1—Mercaptopurine—hematologic cancer	0.0831	0.107	CbGbCtD
Pyrazinamide—XDH—Mercaptopurine—hematologic cancer	0.0718	0.0926	CbGbCtD
Pyrazinamide—XDH—Cisplatin—hematologic cancer	0.0362	0.0466	CbGbCtD
Pyrazinamide—CYP1A2—Anagrelide—hematologic cancer	0.0297	0.0383	CbGbCtD
Pyrazinamide—AOX1—Methotrexate—hematologic cancer	0.0272	0.035	CbGbCtD
Pyrazinamide—XDH—Doxorubicin—hematologic cancer	0.0242	0.0313	CbGbCtD
Pyrazinamide—CYP1A2—Carmustine—hematologic cancer	0.0156	0.0201	CbGbCtD
Pyrazinamide—CYP1A2—Methoxsalen—hematologic cancer	0.0133	0.0171	CbGbCtD
Pyrazinamide—CYP1A2—Bortezomib—hematologic cancer	0.0126	0.0163	CbGbCtD
Pyrazinamide—CYP1A2—Daunorubicin—hematologic cancer	0.0121	0.0156	CbGbCtD
Pyrazinamide—CYP1A2—Alitretinoin—hematologic cancer	0.0118	0.0153	CbGbCtD
Pyrazinamide—CYP1A2—Thalidomide—hematologic cancer	0.011	0.0142	CbGbCtD
Pyrazinamide—CYP3A4—Bexarotene—hematologic cancer	0.0108	0.0139	CbGbCtD
Pyrazinamide—CYP3A4—Lomustine—hematologic cancer	0.01	0.0129	CbGbCtD
Pyrazinamide—CYP3A4—Busulfan—hematologic cancer	0.01	0.0129	CbGbCtD
Pyrazinamide—CYP1A2—Dacarbazine—hematologic cancer	0.00946	0.0122	CbGbCtD
Pyrazinamide—CYP1A2—Imatinib—hematologic cancer	0.00925	0.0119	CbGbCtD
Pyrazinamide—CYP3A4—Thiotepa—hematologic cancer	0.00894	0.0115	CbGbCtD
Pyrazinamide—CYP1A2—Dasatinib—hematologic cancer	0.00743	0.00958	CbGbCtD
Pyrazinamide—CYP3A4—Methoxsalen—hematologic cancer	0.00696	0.00897	CbGbCtD
Pyrazinamide—CYP3A4—Bortezomib—hematologic cancer	0.00662	0.00853	CbGbCtD
Pyrazinamide—CYP3A4—Daunorubicin—hematologic cancer	0.00633	0.00816	CbGbCtD
Pyrazinamide—CYP3A4—Cytarabine—hematologic cancer	0.00558	0.0072	CbGbCtD
Pyrazinamide—CYP3A4—Teniposide—hematologic cancer	0.0055	0.00709	CbGbCtD
Pyrazinamide—CYP3A4—Ifosfamide—hematologic cancer	0.00507	0.00654	CbGbCtD
Pyrazinamide—CYP3A4—Imatinib—hematologic cancer	0.00485	0.00625	CbGbCtD
Pyrazinamide—CYP1A2—Etoposide—hematologic cancer	0.00463	0.00597	CbGbCtD
Pyrazinamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00456	0.00589	CbGbCtD
Pyrazinamide—CYP3A4—Nilotinib—hematologic cancer	0.0044	0.00568	CbGbCtD
Pyrazinamide—CYP3A4—Vinorelbine—hematologic cancer	0.00437	0.00563	CbGbCtD
Pyrazinamide—CYP3A4—Triamcinolone—hematologic cancer	0.00399	0.00515	CbGbCtD
Pyrazinamide—CYP3A4—Dasatinib—hematologic cancer	0.00389	0.00502	CbGbCtD
Pyrazinamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00385	0.00496	CbGbCtD
Pyrazinamide—CYP3A4—Betamethasone—hematologic cancer	0.00343	0.00442	CbGbCtD
Pyrazinamide—CYP3A4—Prednisolone—hematologic cancer	0.00338	0.00436	CbGbCtD
Pyrazinamide—CYP3A4—Prednisone—hematologic cancer	0.00319	0.00412	CbGbCtD
Pyrazinamide—CYP3A4—Irinotecan—hematologic cancer	0.00303	0.00391	CbGbCtD
Pyrazinamide—CYP3A4—Vinblastine—hematologic cancer	0.00269	0.00347	CbGbCtD
Pyrazinamide—CYP3A4—Vincristine—hematologic cancer	0.00265	0.00341	CbGbCtD
Pyrazinamide—CYP3A4—Etoposide—hematologic cancer	0.00242	0.00313	CbGbCtD
Pyrazinamide—CYP3A4—Dexamethasone—hematologic cancer	0.00199	0.00257	CbGbCtD
Pyrazinamide—CYP3A4—Doxorubicin—hematologic cancer	0.00165	0.00213	CbGbCtD
Pyrazinamide—Rash—Lenalidomide—hematologic cancer	9.61e-05	0.000504	CcSEcCtD
Pyrazinamide—Body temperature increased—Carmustine—hematologic cancer	9.6e-05	0.000504	CcSEcCtD
Pyrazinamide—Dermatitis—Lenalidomide—hematologic cancer	9.6e-05	0.000503	CcSEcCtD
Pyrazinamide—Decreased appetite—Gemcitabine—hematologic cancer	9.56e-05	0.000501	CcSEcCtD
Pyrazinamide—Urticaria—Alitretinoin—hematologic cancer	9.56e-05	0.000501	CcSEcCtD
Pyrazinamide—Vomiting—Hydroxyurea—hematologic cancer	9.56e-05	0.000501	CcSEcCtD
Pyrazinamide—Discomfort—Prednisolone—hematologic cancer	9.55e-05	0.000501	CcSEcCtD
Pyrazinamide—Body temperature increased—Alitretinoin—hematologic cancer	9.51e-05	0.000499	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Gemcitabine—hematologic cancer	9.5e-05	0.000498	CcSEcCtD
Pyrazinamide—Rash—Hydroxyurea—hematologic cancer	9.48e-05	0.000497	CcSEcCtD
Pyrazinamide—Dermatitis—Hydroxyurea—hematologic cancer	9.47e-05	0.000496	CcSEcCtD
Pyrazinamide—Urticaria—Ifosfamide—hematologic cancer	9.45e-05	0.000495	CcSEcCtD
Pyrazinamide—Malaise—Triamcinolone—hematologic cancer	9.42e-05	0.000494	CcSEcCtD
Pyrazinamide—Body temperature increased—Ifosfamide—hematologic cancer	9.4e-05	0.000493	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Cisplatin—hematologic cancer	9.34e-05	0.00049	CcSEcCtD
Pyrazinamide—Hypersensitivity—Thalidomide—hematologic cancer	9.32e-05	0.000489	CcSEcCtD
Pyrazinamide—Nausea—Melphalan—hematologic cancer	9.31e-05	0.000488	CcSEcCtD
Pyrazinamide—Feeling abnormal—Mitoxantrone—hematologic cancer	9.31e-05	0.000488	CcSEcCtD
Pyrazinamide—Feeling abnormal—Irinotecan—hematologic cancer	9.31e-05	0.000488	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—hematologic cancer	9.25e-05	0.000485	CcSEcCtD
Pyrazinamide—Pruritus—Thiotepa—hematologic cancer	9.25e-05	0.000485	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Etoposide—hematologic cancer	9.2e-05	0.000482	CcSEcCtD
Pyrazinamide—Body temperature increased—Vincristine—hematologic cancer	9.17e-05	0.000481	CcSEcCtD
Pyrazinamide—Feeling abnormal—Gemcitabine—hematologic cancer	9.07e-05	0.000475	CcSEcCtD
Pyrazinamide—Nausea—Lenalidomide—hematologic cancer	9.05e-05	0.000475	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—hematologic cancer	9.03e-05	0.000474	CcSEcCtD
Pyrazinamide—Urticaria—Mitoxantrone—hematologic cancer	8.97e-05	0.00047	CcSEcCtD
Pyrazinamide—Anorexia—Etoposide—hematologic cancer	8.96e-05	0.00047	CcSEcCtD
Pyrazinamide—Hypersensitivity—Carmustine—hematologic cancer	8.95e-05	0.000469	CcSEcCtD
Pyrazinamide—Pruritus—Thalidomide—hematologic cancer	8.95e-05	0.000469	CcSEcCtD
Pyrazinamide—Body temperature increased—Mitoxantrone—hematologic cancer	8.93e-05	0.000468	CcSEcCtD
Pyrazinamide—Body temperature increased—Irinotecan—hematologic cancer	8.93e-05	0.000468	CcSEcCtD
Pyrazinamide—Nausea—Hydroxyurea—hematologic cancer	8.93e-05	0.000468	CcSEcCtD
Pyrazinamide—Vomiting—Bortezomib—hematologic cancer	8.92e-05	0.000468	CcSEcCtD
Pyrazinamide—Decreased appetite—Cisplatin—hematologic cancer	8.91e-05	0.000467	CcSEcCtD
Pyrazinamide—Myalgia—Triamcinolone—hematologic cancer	8.89e-05	0.000466	CcSEcCtD
Pyrazinamide—Hypersensitivity—Alitretinoin—hematologic cancer	8.87e-05	0.000465	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Cisplatin—hematologic cancer	8.85e-05	0.000464	CcSEcCtD
Pyrazinamide—Vomiting—Bleomycin—hematologic cancer	8.85e-05	0.000464	CcSEcCtD
Pyrazinamide—Rash—Bortezomib—hematologic cancer	8.84e-05	0.000464	CcSEcCtD
Pyrazinamide—Dermatitis—Bortezomib—hematologic cancer	8.84e-05	0.000463	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dexamethasone—hematologic cancer	8.79e-05	0.000461	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Betamethasone—hematologic cancer	8.79e-05	0.000461	CcSEcCtD
Pyrazinamide—Discomfort—Triamcinolone—hematologic cancer	8.78e-05	0.00046	CcSEcCtD
Pyrazinamide—Rash—Bleomycin—hematologic cancer	8.78e-05	0.00046	CcSEcCtD
Pyrazinamide—Dermatitis—Bleomycin—hematologic cancer	8.77e-05	0.00046	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ifosfamide—hematologic cancer	8.76e-05	0.000459	CcSEcCtD
Pyrazinamide—Vomiting—Vinorelbine—hematologic cancer	8.71e-05	0.000457	CcSEcCtD
Pyrazinamide—Body temperature increased—Gemcitabine—hematologic cancer	8.7e-05	0.000456	CcSEcCtD
Pyrazinamide—Dysuria—Epirubicin—hematologic cancer	8.66e-05	0.000454	CcSEcCtD
Pyrazinamide—Rash—Vinorelbine—hematologic cancer	8.63e-05	0.000453	CcSEcCtD
Pyrazinamide—Dermatitis—Vinorelbine—hematologic cancer	8.63e-05	0.000452	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vincristine—hematologic cancer	8.54e-05	0.000448	CcSEcCtD
Pyrazinamide—Malaise—Betamethasone—hematologic cancer	8.54e-05	0.000448	CcSEcCtD
Pyrazinamide—Malaise—Dexamethasone—hematologic cancer	8.54e-05	0.000448	CcSEcCtD
Pyrazinamide—Pruritus—Alitretinoin—hematologic cancer	8.52e-05	0.000446	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Epirubicin—hematologic cancer	8.45e-05	0.000443	CcSEcCtD
Pyrazinamide—Feeling abnormal—Cisplatin—hematologic cancer	8.45e-05	0.000443	CcSEcCtD
Pyrazinamide—Pruritus—Ifosfamide—hematologic cancer	8.42e-05	0.000441	CcSEcCtD
Pyrazinamide—Nausea—Bortezomib—hematologic cancer	8.33e-05	0.000437	CcSEcCtD
Pyrazinamide—Hypersensitivity—Irinotecan—hematologic cancer	8.32e-05	0.000436	CcSEcCtD
Pyrazinamide—Hypersensitivity—Mitoxantrone—hematologic cancer	8.32e-05	0.000436	CcSEcCtD
Pyrazinamide—Vomiting—Thiotepa—hematologic cancer	8.32e-05	0.000436	CcSEcCtD
Pyrazinamide—Nausea—Bleomycin—hematologic cancer	8.27e-05	0.000433	CcSEcCtD
Pyrazinamide—Rash—Thiotepa—hematologic cancer	8.25e-05	0.000432	CcSEcCtD
Pyrazinamide—Dermatitis—Thiotepa—hematologic cancer	8.24e-05	0.000432	CcSEcCtD
Pyrazinamide—Decreased appetite—Etoposide—hematologic cancer	8.17e-05	0.000428	CcSEcCtD
Pyrazinamide—Nausea—Vinorelbine—hematologic cancer	8.13e-05	0.000426	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Etoposide—hematologic cancer	8.11e-05	0.000425	CcSEcCtD
Pyrazinamide—Body temperature increased—Cisplatin—hematologic cancer	8.11e-05	0.000425	CcSEcCtD
Pyrazinamide—Myalgia—Dexamethasone—hematologic cancer	8.07e-05	0.000423	CcSEcCtD
Pyrazinamide—Myalgia—Betamethasone—hematologic cancer	8.07e-05	0.000423	CcSEcCtD
Pyrazinamide—Vomiting—Thalidomide—hematologic cancer	8.04e-05	0.000422	CcSEcCtD
Pyrazinamide—Dysuria—Doxorubicin—hematologic cancer	8.01e-05	0.00042	CcSEcCtD
Pyrazinamide—Rash—Thalidomide—hematologic cancer	7.98e-05	0.000418	CcSEcCtD
Pyrazinamide—Discomfort—Betamethasone—hematologic cancer	7.97e-05	0.000418	CcSEcCtD
Pyrazinamide—Discomfort—Dexamethasone—hematologic cancer	7.97e-05	0.000418	CcSEcCtD
Pyrazinamide—Dermatitis—Thalidomide—hematologic cancer	7.97e-05	0.000418	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—hematologic cancer	7.92e-05	0.000415	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Doxorubicin—hematologic cancer	7.82e-05	0.00041	CcSEcCtD
Pyrazinamide—Pruritus—Gemcitabine—hematologic cancer	7.78e-05	0.000408	CcSEcCtD
Pyrazinamide—Nausea—Thiotepa—hematologic cancer	7.77e-05	0.000407	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.76e-05	0.000407	CcSEcCtD
Pyrazinamide—Feeling abnormal—Etoposide—hematologic cancer	7.74e-05	0.000406	CcSEcCtD
Pyrazinamide—Vomiting—Carmustine—hematologic cancer	7.72e-05	0.000405	CcSEcCtD
Pyrazinamide—Rash—Carmustine—hematologic cancer	7.66e-05	0.000402	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisone—hematologic cancer	7.65e-05	0.000401	CcSEcCtD
Pyrazinamide—Dermatitis—Carmustine—hematologic cancer	7.65e-05	0.000401	CcSEcCtD
Pyrazinamide—Vomiting—Alitretinoin—hematologic cancer	7.65e-05	0.000401	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisolone—hematologic cancer	7.64e-05	0.0004	CcSEcCtD
Pyrazinamide—Rash—Alitretinoin—hematologic cancer	7.59e-05	0.000398	CcSEcCtD
Pyrazinamide—Dermatitis—Alitretinoin—hematologic cancer	7.58e-05	0.000397	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dexamethasone—hematologic cancer	7.57e-05	0.000397	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Betamethasone—hematologic cancer	7.57e-05	0.000397	CcSEcCtD
Pyrazinamide—Vomiting—Ifosfamide—hematologic cancer	7.56e-05	0.000397	CcSEcCtD
Pyrazinamide—Hypersensitivity—Cisplatin—hematologic cancer	7.56e-05	0.000396	CcSEcCtD
Pyrazinamide—Nausea—Thalidomide—hematologic cancer	7.51e-05	0.000394	CcSEcCtD
Pyrazinamide—Dyspepsia—Triamcinolone—hematologic cancer	7.5e-05	0.000393	CcSEcCtD
Pyrazinamide—Rash—Ifosfamide—hematologic cancer	7.5e-05	0.000393	CcSEcCtD
Pyrazinamide—Dermatitis—Ifosfamide—hematologic cancer	7.49e-05	0.000393	CcSEcCtD
Pyrazinamide—Urticaria—Etoposide—hematologic cancer	7.46e-05	0.000391	CcSEcCtD
Pyrazinamide—Malaise—Prednisone—hematologic cancer	7.44e-05	0.00039	CcSEcCtD
Pyrazinamide—Body temperature increased—Etoposide—hematologic cancer	7.43e-05	0.000389	CcSEcCtD
Pyrazinamide—Hepatitis—Epirubicin—hematologic cancer	7.41e-05	0.000389	CcSEcCtD
Pyrazinamide—Vomiting—Vincristine—hematologic cancer	7.37e-05	0.000387	CcSEcCtD
Pyrazinamide—Anorexia—Betamethasone—hematologic cancer	7.37e-05	0.000386	CcSEcCtD
Pyrazinamide—Anorexia—Dexamethasone—hematologic cancer	7.37e-05	0.000386	CcSEcCtD
Pyrazinamide—Urticaria—Prednisolone—hematologic cancer	7.36e-05	0.000386	CcSEcCtD
Pyrazinamide—Rash—Vincristine—hematologic cancer	7.31e-05	0.000383	CcSEcCtD
Pyrazinamide—Dermatitis—Vincristine—hematologic cancer	7.31e-05	0.000383	CcSEcCtD
Pyrazinamide—Nausea—Carmustine—hematologic cancer	7.22e-05	0.000378	CcSEcCtD
Pyrazinamide—Vomiting—Mitoxantrone—hematologic cancer	7.18e-05	0.000376	CcSEcCtD
Pyrazinamide—Vomiting—Irinotecan—hematologic cancer	7.18e-05	0.000376	CcSEcCtD
Pyrazinamide—Nausea—Alitretinoin—hematologic cancer	7.15e-05	0.000375	CcSEcCtD
Pyrazinamide—Rash—Mitoxantrone—hematologic cancer	7.12e-05	0.000373	CcSEcCtD
Pyrazinamide—Rash—Irinotecan—hematologic cancer	7.12e-05	0.000373	CcSEcCtD
Pyrazinamide—Dermatitis—Irinotecan—hematologic cancer	7.11e-05	0.000373	CcSEcCtD
Pyrazinamide—Dermatitis—Mitoxantrone—hematologic cancer	7.11e-05	0.000373	CcSEcCtD
Pyrazinamide—Nausea—Ifosfamide—hematologic cancer	7.07e-05	0.00037	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.04e-05	0.000369	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.04e-05	0.000369	CcSEcCtD
Pyrazinamide—Myalgia—Prednisone—hematologic cancer	7.02e-05	0.000368	CcSEcCtD
Pyrazinamide—Arthralgia—Prednisone—hematologic cancer	7.02e-05	0.000368	CcSEcCtD
Pyrazinamide—Feeling abnormal—Triamcinolone—hematologic cancer	7.02e-05	0.000368	CcSEcCtD
Pyrazinamide—Vomiting—Gemcitabine—hematologic cancer	7e-05	0.000367	CcSEcCtD
Pyrazinamide—Discomfort—Prednisone—hematologic cancer	6.94e-05	0.000364	CcSEcCtD
Pyrazinamide—Rash—Gemcitabine—hematologic cancer	6.94e-05	0.000364	CcSEcCtD
Pyrazinamide—Dermatitis—Gemcitabine—hematologic cancer	6.93e-05	0.000363	CcSEcCtD
Pyrazinamide—Hypersensitivity—Etoposide—hematologic cancer	6.92e-05	0.000363	CcSEcCtD
Pyrazinamide—Nausea—Vincristine—hematologic cancer	6.89e-05	0.000361	CcSEcCtD
Pyrazinamide—Hepatitis—Doxorubicin—hematologic cancer	6.86e-05	0.00036	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisolone—hematologic cancer	6.83e-05	0.000358	CcSEcCtD
Pyrazinamide—Dyspepsia—Betamethasone—hematologic cancer	6.81e-05	0.000357	CcSEcCtD
Pyrazinamide—Dyspepsia—Dexamethasone—hematologic cancer	6.81e-05	0.000357	CcSEcCtD
Pyrazinamide—Urticaria—Triamcinolone—hematologic cancer	6.77e-05	0.000355	CcSEcCtD
Pyrazinamide—Body temperature increased—Triamcinolone—hematologic cancer	6.74e-05	0.000353	CcSEcCtD
Pyrazinamide—Decreased appetite—Dexamethasone—hematologic cancer	6.72e-05	0.000352	CcSEcCtD
Pyrazinamide—Decreased appetite—Betamethasone—hematologic cancer	6.72e-05	0.000352	CcSEcCtD
Pyrazinamide—Nausea—Mitoxantrone—hematologic cancer	6.71e-05	0.000352	CcSEcCtD
Pyrazinamide—Nausea—Irinotecan—hematologic cancer	6.71e-05	0.000352	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.68e-05	0.00035	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.68e-05	0.00035	CcSEcCtD
Pyrazinamide—Pruritus—Etoposide—hematologic cancer	6.65e-05	0.000348	CcSEcCtD
Pyrazinamide—Nausea—Gemcitabine—hematologic cancer	6.53e-05	0.000343	CcSEcCtD
Pyrazinamide—Vomiting—Cisplatin—hematologic cancer	6.52e-05	0.000342	CcSEcCtD
Pyrazinamide—Rash—Cisplatin—hematologic cancer	6.47e-05	0.000339	CcSEcCtD
Pyrazinamide—Dermatitis—Cisplatin—hematologic cancer	6.46e-05	0.000339	CcSEcCtD
Pyrazinamide—Anorexia—Prednisone—hematologic cancer	6.42e-05	0.000337	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—hematologic cancer	6.4e-05	0.000335	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dexamethasone—hematologic cancer	6.37e-05	0.000334	CcSEcCtD
Pyrazinamide—Feeling abnormal—Betamethasone—hematologic cancer	6.37e-05	0.000334	CcSEcCtD
Pyrazinamide—Hypersensitivity—Triamcinolone—hematologic cancer	6.28e-05	0.000329	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—hematologic cancer	6.22e-05	0.000326	CcSEcCtD
Pyrazinamide—Urticaria—Dexamethasone—hematologic cancer	6.14e-05	0.000322	CcSEcCtD
Pyrazinamide—Urticaria—Betamethasone—hematologic cancer	6.14e-05	0.000322	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.13e-05	0.000322	CcSEcCtD
Pyrazinamide—Body temperature increased—Dexamethasone—hematologic cancer	6.11e-05	0.00032	CcSEcCtD
Pyrazinamide—Body temperature increased—Betamethasone—hematologic cancer	6.11e-05	0.00032	CcSEcCtD
Pyrazinamide—Nausea—Cisplatin—hematologic cancer	6.09e-05	0.000319	CcSEcCtD
Pyrazinamide—Pruritus—Triamcinolone—hematologic cancer	6.03e-05	0.000316	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Epirubicin—hematologic cancer	5.99e-05	0.000314	CcSEcCtD
Pyrazinamide—Vomiting—Etoposide—hematologic cancer	5.97e-05	0.000313	CcSEcCtD
Pyrazinamide—Dyspepsia—Prednisone—hematologic cancer	5.93e-05	0.000311	CcSEcCtD
Pyrazinamide—Rash—Etoposide—hematologic cancer	5.92e-05	0.000311	CcSEcCtD
Pyrazinamide—Dermatitis—Etoposide—hematologic cancer	5.92e-05	0.00031	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—hematologic cancer	5.87e-05	0.000308	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—hematologic cancer	5.87e-05	0.000308	CcSEcCtD
Pyrazinamide—Decreased appetite—Prednisone—hematologic cancer	5.85e-05	0.000307	CcSEcCtD
Pyrazinamide—Rash—Prednisolone—hematologic cancer	5.84e-05	0.000306	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisolone—hematologic cancer	5.84e-05	0.000306	CcSEcCtD
Pyrazinamide—Malaise—Epirubicin—hematologic cancer	5.82e-05	0.000305	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—hematologic cancer	5.8e-05	0.000304	CcSEcCtD
Pyrazinamide—Nausea—Etoposide—hematologic cancer	5.58e-05	0.000293	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisone—hematologic cancer	5.55e-05	0.000291	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Doxorubicin—hematologic cancer	5.54e-05	0.00029	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—hematologic cancer	5.51e-05	0.000289	CcSEcCtD
Pyrazinamide—Nausea—Prednisolone—hematologic cancer	5.5e-05	0.000289	CcSEcCtD
Pyrazinamide—Arthralgia—Epirubicin—hematologic cancer	5.49e-05	0.000288	CcSEcCtD
Pyrazinamide—Myalgia—Epirubicin—hematologic cancer	5.49e-05	0.000288	CcSEcCtD
Pyrazinamide—Pruritus—Dexamethasone—hematologic cancer	5.47e-05	0.000287	CcSEcCtD
Pyrazinamide—Pruritus—Betamethasone—hematologic cancer	5.47e-05	0.000287	CcSEcCtD
Pyrazinamide—Discomfort—Epirubicin—hematologic cancer	5.43e-05	0.000285	CcSEcCtD
Pyrazinamide—Vomiting—Triamcinolone—hematologic cancer	5.42e-05	0.000284	CcSEcCtD
Pyrazinamide—Malaise—Doxorubicin—hematologic cancer	5.38e-05	0.000282	CcSEcCtD
Pyrazinamide—Rash—Triamcinolone—hematologic cancer	5.37e-05	0.000282	CcSEcCtD
Pyrazinamide—Dermatitis—Triamcinolone—hematologic cancer	5.37e-05	0.000281	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—hematologic cancer	5.36e-05	0.000281	CcSEcCtD
Pyrazinamide—Urticaria—Prednisone—hematologic cancer	5.35e-05	0.00028	CcSEcCtD
Pyrazinamide—Body temperature increased—Prednisone—hematologic cancer	5.32e-05	0.000279	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Epirubicin—hematologic cancer	5.16e-05	0.00027	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.13e-05	0.000269	CcSEcCtD
Pyrazinamide—Arthralgia—Doxorubicin—hematologic cancer	5.08e-05	0.000266	CcSEcCtD
Pyrazinamide—Myalgia—Doxorubicin—hematologic cancer	5.08e-05	0.000266	CcSEcCtD
Pyrazinamide—Nausea—Triamcinolone—hematologic cancer	5.06e-05	0.000265	CcSEcCtD
Pyrazinamide—Discomfort—Doxorubicin—hematologic cancer	5.02e-05	0.000263	CcSEcCtD
Pyrazinamide—Anorexia—Epirubicin—hematologic cancer	5.02e-05	0.000263	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisone—hematologic cancer	4.96e-05	0.00026	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—hematologic cancer	4.95e-05	0.00026	CcSEcCtD
Pyrazinamide—Vomiting—Dexamethasone—hematologic cancer	4.92e-05	0.000258	CcSEcCtD
Pyrazinamide—Vomiting—Betamethasone—hematologic cancer	4.92e-05	0.000258	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—hematologic cancer	4.89e-05	0.000256	CcSEcCtD
Pyrazinamide—Rash—Dexamethasone—hematologic cancer	4.87e-05	0.000256	CcSEcCtD
Pyrazinamide—Rash—Betamethasone—hematologic cancer	4.87e-05	0.000256	CcSEcCtD
Pyrazinamide—Dermatitis—Dexamethasone—hematologic cancer	4.87e-05	0.000255	CcSEcCtD
Pyrazinamide—Dermatitis—Betamethasone—hematologic cancer	4.87e-05	0.000255	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.86e-05	0.000255	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.8e-05	0.000252	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Doxorubicin—hematologic cancer	4.77e-05	0.00025	CcSEcCtD
Pyrazinamide—Pruritus—Prednisone—hematologic cancer	4.76e-05	0.00025	CcSEcCtD
Pyrazinamide—Anorexia—Doxorubicin—hematologic cancer	4.64e-05	0.000244	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—hematologic cancer	4.64e-05	0.000243	CcSEcCtD
Pyrazinamide—Dyspepsia—Epirubicin—hematologic cancer	4.64e-05	0.000243	CcSEcCtD
Pyrazinamide—Nausea—Dexamethasone—hematologic cancer	4.59e-05	0.000241	CcSEcCtD
Pyrazinamide—Nausea—Betamethasone—hematologic cancer	4.59e-05	0.000241	CcSEcCtD
Pyrazinamide—Decreased appetite—Epirubicin—hematologic cancer	4.58e-05	0.00024	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.55e-05	0.000238	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—hematologic cancer	4.47e-05	0.000234	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—hematologic cancer	4.45e-05	0.000233	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.44e-05	0.000233	CcSEcCtD
Pyrazinamide—Feeling abnormal—Epirubicin—hematologic cancer	4.34e-05	0.000228	CcSEcCtD
Pyrazinamide—Dyspepsia—Doxorubicin—hematologic cancer	4.29e-05	0.000225	CcSEcCtD
Pyrazinamide—Vomiting—Prednisone—hematologic cancer	4.28e-05	0.000224	CcSEcCtD
Pyrazinamide—Rash—Prednisone—hematologic cancer	4.25e-05	0.000223	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisone—hematologic cancer	4.24e-05	0.000222	CcSEcCtD
Pyrazinamide—Decreased appetite—Doxorubicin—hematologic cancer	4.24e-05	0.000222	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.21e-05	0.000221	CcSEcCtD
Pyrazinamide—Urticaria—Epirubicin—hematologic cancer	4.18e-05	0.000219	CcSEcCtD
Pyrazinamide—Body temperature increased—Epirubicin—hematologic cancer	4.16e-05	0.000218	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—hematologic cancer	4.15e-05	0.000217	CcSEcCtD
Pyrazinamide—Feeling abnormal—Doxorubicin—hematologic cancer	4.02e-05	0.000211	CcSEcCtD
Pyrazinamide—Nausea—Prednisone—hematologic cancer	4e-05	0.00021	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—hematologic cancer	3.98e-05	0.000209	CcSEcCtD
Pyrazinamide—Hypersensitivity—Epirubicin—hematologic cancer	3.88e-05	0.000203	CcSEcCtD
Pyrazinamide—Urticaria—Doxorubicin—hematologic cancer	3.87e-05	0.000203	CcSEcCtD
Pyrazinamide—Body temperature increased—Doxorubicin—hematologic cancer	3.85e-05	0.000202	CcSEcCtD
Pyrazinamide—Pruritus—Epirubicin—hematologic cancer	3.73e-05	0.000195	CcSEcCtD
Pyrazinamide—Hypersensitivity—Doxorubicin—hematologic cancer	3.59e-05	0.000188	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—hematologic cancer	3.58e-05	0.000188	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—hematologic cancer	3.55e-05	0.000186	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—hematologic cancer	3.54e-05	0.000186	CcSEcCtD
Pyrazinamide—Pruritus—Doxorubicin—hematologic cancer	3.45e-05	0.000181	CcSEcCtD
Pyrazinamide—Vomiting—Epirubicin—hematologic cancer	3.35e-05	0.000176	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—hematologic cancer	3.34e-05	0.000175	CcSEcCtD
Pyrazinamide—Rash—Epirubicin—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Pyrazinamide—Dermatitis—Epirubicin—hematologic cancer	3.32e-05	0.000174	CcSEcCtD
Pyrazinamide—Nausea—Epirubicin—hematologic cancer	3.13e-05	0.000164	CcSEcCtD
Pyrazinamide—Vomiting—Doxorubicin—hematologic cancer	3.1e-05	0.000162	CcSEcCtD
Pyrazinamide—Rash—Doxorubicin—hematologic cancer	3.07e-05	0.000161	CcSEcCtD
Pyrazinamide—Dermatitis—Doxorubicin—hematologic cancer	3.07e-05	0.000161	CcSEcCtD
Pyrazinamide—Nausea—Doxorubicin—hematologic cancer	2.89e-05	0.000152	CcSEcCtD
Pyrazinamide—AOX1—Disease—HSP90AA1—hematologic cancer	2.69e-05	0.000792	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTT1—hematologic cancer	2.68e-05	0.00079	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	2.68e-05	0.000789	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—MTR—hematologic cancer	2.68e-05	0.000788	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	2.65e-05	0.000779	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SDC1—hematologic cancer	2.62e-05	0.000772	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT1—hematologic cancer	2.6e-05	0.000764	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	2.55e-05	0.000749	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.54e-05	0.000746	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	2.47e-05	0.000726	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.46e-05	0.000724	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—GRB2—hematologic cancer	2.43e-05	0.000715	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFA—hematologic cancer	2.42e-05	0.000713	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CD44—hematologic cancer	2.4e-05	0.000706	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NQO1—hematologic cancer	2.4e-05	0.000706	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KITLG—hematologic cancer	2.39e-05	0.000703	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT5A—hematologic cancer	2.33e-05	0.000687	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN2B—hematologic cancer	2.31e-05	0.000681	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	2.3e-05	0.000676	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.3e-05	0.000676	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	2.29e-05	0.000673	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	2.28e-05	0.000671	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYCS—hematologic cancer	2.27e-05	0.000668	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	2.26e-05	0.000664	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HSP90AA1—hematologic cancer	2.25e-05	0.000664	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD86—hematologic cancer	2.24e-05	0.000659	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CD44—hematologic cancer	2.23e-05	0.000656	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NQO1—hematologic cancer	2.23e-05	0.000656	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HES1—hematologic cancer	2.21e-05	0.00065	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NCOR1—hematologic cancer	2.19e-05	0.000646	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF1—hematologic cancer	2.17e-05	0.000639	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FOXO1—hematologic cancer	2.14e-05	0.00063	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFRB—hematologic cancer	2.14e-05	0.000628	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYCS—hematologic cancer	2.11e-05	0.000621	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFRA—hematologic cancer	2.1e-05	0.000619	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	2.1e-05	0.000619	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HSP90AA1—hematologic cancer	2.1e-05	0.000617	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—JAK1—hematologic cancer	2.09e-05	0.000617	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PRKCG—hematologic cancer	2.09e-05	0.000617	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.07e-05	0.00061	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.07e-05	0.000608	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTP1—hematologic cancer	2e-05	0.000589	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—hematologic cancer	1.94e-05	0.000571	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	1.94e-05	0.00057	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TERT—hematologic cancer	1.93e-05	0.000569	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HLA-A—hematologic cancer	1.93e-05	0.000569	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCB1—hematologic cancer	1.89e-05	0.000557	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFB—hematologic cancer	1.89e-05	0.000556	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTP1—hematologic cancer	1.86e-05	0.000547	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TSC2—hematologic cancer	1.85e-05	0.000543	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NCOR1—hematologic cancer	1.84e-05	0.000541	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—hematologic cancer	1.84e-05	0.000541	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.81e-05	0.000532	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGFR3—hematologic cancer	1.78e-05	0.000522	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.77e-05	0.00052	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCB1—hematologic cancer	1.76e-05	0.000518	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FTCD—hematologic cancer	1.75e-05	0.000516	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GMPS—hematologic cancer	1.75e-05	0.000516	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PHYH—hematologic cancer	1.75e-05	0.000516	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.74e-05	0.000512	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.73e-05	0.000511	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—hematologic cancer	1.71e-05	0.000503	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NCOR1—hematologic cancer	1.71e-05	0.000503	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BAD—hematologic cancer	1.68e-05	0.000495	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOTCH1—hematologic cancer	1.67e-05	0.00049	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.65e-05	0.000486	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.63e-05	0.000481	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD80—hematologic cancer	1.63e-05	0.000481	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KIT—hematologic cancer	1.63e-05	0.00048	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—hematologic cancer	1.62e-05	0.000478	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.62e-05	0.000477	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.6e-05	0.000472	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTPN11—hematologic cancer	1.6e-05	0.000471	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.6e-05	0.000471	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.6e-05	0.000471	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CREB1—hematologic cancer	1.55e-05	0.000457	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BRAF—hematologic cancer	1.53e-05	0.000451	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6R—hematologic cancer	1.51e-05	0.000445	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CREBBP—hematologic cancer	1.51e-05	0.000445	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—hematologic cancer	1.51e-05	0.000444	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.49e-05	0.00044	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.46e-05	0.000429	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAP2K1—hematologic cancer	1.44e-05	0.000424	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CD—hematologic cancer	1.43e-05	0.000422	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.4e-05	0.000412	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DCK—hematologic cancer	1.4e-05	0.000412	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ASNS—hematologic cancer	1.4e-05	0.000412	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF2—hematologic cancer	1.37e-05	0.000404	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.37e-05	0.000403	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CG—hematologic cancer	1.36e-05	0.000402	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3R1—hematologic cancer	1.35e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GMPS—hematologic cancer	1.35e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FTCD—hematologic cancer	1.35e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PHYH—hematologic cancer	1.35e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HDC—hematologic cancer	1.33e-05	0.000391	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—JAK2—hematologic cancer	1.31e-05	0.000387	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MDM2—hematologic cancer	1.28e-05	0.000378	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CG—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CREBBP—hematologic cancer	1.27e-05	0.000372	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CB—hematologic cancer	1.25e-05	0.000368	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTOR—hematologic cancer	1.25e-05	0.000368	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD4—hematologic cancer	1.25e-05	0.000367	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.24e-05	0.000364	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.24e-05	0.000364	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CDA—hematologic cancer	1.21e-05	0.000358	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CD—hematologic cancer	1.2e-05	0.000353	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—hematologic cancer	1.18e-05	0.000349	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CREBBP—hematologic cancer	1.18e-05	0.000346	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1B—hematologic cancer	1.17e-05	0.000345	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PC—hematologic cancer	1.17e-05	0.000344	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3R1—hematologic cancer	1.13e-05	0.000333	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.13e-05	0.000332	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GBA—hematologic cancer	1.13e-05	0.000332	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CD—hematologic cancer	1.12e-05	0.000328	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—hematologic cancer	1.1e-05	0.000324	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1A—hematologic cancer	1.08e-05	0.000318	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.08e-05	0.000318	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DCK—hematologic cancer	1.08e-05	0.000318	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ASNS—hematologic cancer	1.08e-05	0.000318	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTEN—hematologic cancer	1.08e-05	0.000318	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3R1—hematologic cancer	1.05e-05	0.00031	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CB—hematologic cancer	1.05e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTAP—hematologic cancer	1.03e-05	0.000304	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EP300—hematologic cancer	1.03e-05	0.000303	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HDC—hematologic cancer	1.03e-05	0.000302	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SRC—hematologic cancer	1e-05	0.000295	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CB—hematologic cancer	9.72e-06	0.000286	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—hematologic cancer	9.65e-06	0.000284	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NRAS—hematologic cancer	9.63e-06	0.000283	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CDA—hematologic cancer	9.38e-06	0.000276	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—hematologic cancer	9.22e-06	0.000271	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FHL2—hematologic cancer	9.21e-06	0.000271	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTEN—hematologic cancer	9.04e-06	0.000266	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AGRN—hematologic cancer	9.03e-06	0.000266	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PC—hematologic cancer	9.02e-06	0.000266	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MYC—hematologic cancer	8.97e-06	0.000264	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—hematologic cancer	8.95e-06	0.000263	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GBA—hematologic cancer	8.72e-06	0.000257	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.72e-06	0.000257	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—EP300—hematologic cancer	8.62e-06	0.000254	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—IDH2—hematologic cancer	8.56e-06	0.000252	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMMR—hematologic cancer	8.56e-06	0.000252	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTEN—hematologic cancer	8.4e-06	0.000247	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KRAS—hematologic cancer	8.29e-06	0.000244	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.07e-06	0.000238	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.05e-06	0.000237	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—EP300—hematologic cancer	8.01e-06	0.000236	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTAP—hematologic cancer	7.97e-06	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA9—hematologic cancer	7.83e-06	0.00023	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ACP5—hematologic cancer	7.83e-06	0.00023	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.73e-06	0.000227	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—hematologic cancer	7.61e-06	0.000224	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—IDH1—hematologic cancer	7.36e-06	0.000217	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.28e-06	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TXN—hematologic cancer	7.28e-06	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.28e-06	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.12e-06	0.00021	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FHL2—hematologic cancer	7.11e-06	0.000209	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—hematologic cancer	7.04e-06	0.000207	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AGRN—hematologic cancer	6.97e-06	0.000205	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.84e-06	0.000201	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—hematologic cancer	6.74e-06	0.000198	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.66e-06	0.000196	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.66e-06	0.000196	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—IDH2—hematologic cancer	6.61e-06	0.000194	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMMR—hematologic cancer	6.61e-06	0.000194	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.49e-06	0.000191	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—hematologic cancer	6.38e-06	0.000188	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NUP98—hematologic cancer	6.28e-06	0.000185	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—hematologic cancer	6.22e-06	0.000183	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.21e-06	0.000183	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.1e-06	0.000179	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.1e-06	0.000179	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NUP214—hematologic cancer	6.06e-06	0.000178	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ACP5—hematologic cancer	6.04e-06	0.000178	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA9—hematologic cancer	6.04e-06	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.99e-06	0.000176	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.96e-06	0.000175	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.93e-06	0.000175	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTR—hematologic cancer	5.93e-06	0.000175	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—hematologic cancer	5.93e-06	0.000174	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENO2—hematologic cancer	5.82e-06	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—IDH1—hematologic cancer	5.68e-06	0.000167	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.64e-06	0.000166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TXN—hematologic cancer	5.62e-06	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.62e-06	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.62e-06	0.000165	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.56e-06	0.000164	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SDC1—hematologic cancer	5.52e-06	0.000162	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.5e-06	0.000162	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.28e-06	0.000155	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.27e-06	0.000155	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—hematologic cancer	5.21e-06	0.000153	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.2e-06	0.000153	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.14e-06	0.000151	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.14e-06	0.000151	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.01e-06	0.000147	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.97e-06	0.000146	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NUP98—hematologic cancer	4.85e-06	0.000143	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—hematologic cancer	4.84e-06	0.000143	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.71e-06	0.000139	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.71e-06	0.000139	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD44—hematologic cancer	4.69e-06	0.000138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NQO1—hematologic cancer	4.69e-06	0.000138	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NUP214—hematologic cancer	4.67e-06	0.000138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.59e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.58e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTR—hematologic cancer	4.58e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENO2—hematologic cancer	4.49e-06	0.000132	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYCS—hematologic cancer	4.44e-06	0.000131	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.41e-06	0.00013	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.35e-06	0.000128	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SDC1—hematologic cancer	4.26e-06	0.000125	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.97e-06	0.000117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.91e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.78e-06	0.000111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.7e-06	0.000109	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NQO1—hematologic cancer	3.62e-06	0.000107	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD44—hematologic cancer	3.62e-06	0.000107	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.59e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.59e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYCS—hematologic cancer	3.42e-06	0.000101	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.4e-06	0.0001	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.18e-06	9.35e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.02e-06	8.88e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.86e-06	8.41e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.8e-06	8.24e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.77e-06	8.16e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.77e-06	8.16e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.67e-06	7.86e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.47e-06	7.28e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.45e-06	7.22e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.35e-06	6.91e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—hematologic cancer	2.32e-06	6.82e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.22e-06	6.52e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.06e-06	6.06e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.05e-06	6.02e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.91e-06	5.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.81e-06	5.33e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.79e-06	5.26e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTEN—hematologic cancer	1.77e-06	5.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.71e-06	5.03e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—EP300—hematologic cancer	1.69e-06	4.96e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.58e-06	4.65e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.36e-06	4.01e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—EP300—hematologic cancer	1.3e-06	3.83e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.25e-06	3.67e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—hematologic cancer	1.02e-06	3e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.62e-07	2.83e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—hematologic cancer	7.86e-07	2.31e-05	CbGpPWpGaD
